Total planned funding: $146,313,040
Allocations
Countries/Regions
Ukraine | $146,313,040 |
Organizational Types
Unknown | $34,968,021 |
Private Contractor | $34,064,481 |
NGO | $28,369,854 |
Multi-lateral Agency | $16,301,607 |
Own Agency | $16,013,383 |
University | $6,627,000 |
Other USG Agency | $5,346,694 |
Implementing Agency | $4,372,000 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $65,098,964 |
Treatment | $24,931,622 |
Prevention | $19,638,472 |
Testing | $12,641,398 |
Care | $12,425,282 |
Management and Operations | $11,164,602 |
Budget Codes
OHSS: Health Systems Strengthening | $32,851,984 |
HVSI: Strategic Information | $18,567,540 |
HLAB: Laboratory Infrastructure | $13,679,440 |
HTXS: Treatment: Adult Treatment | $13,500,508 |
HVCT: Testing: HIV Testing and Counseling | $12,641,398 |
HTXD: Treatment: ARV Drugs | $11,431,114 |
HVMS: Management and Operations | $11,164,602 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $8,792,018 |
HVTB: Care: TB/HIV | $7,857,243 |
HVOP: Sexual Prevention: Other Sexual Prevention | $7,314,689 |
HMBL: Biomedical Prevention: Blood Safety | $2,769,414 |
HKID: Care: Orphans and Vulnerable Children | $2,319,238 |
HBHC: Care: Adult Care and Support | $2,248,801 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $218,994 |
Top Partner Programs
Not Available:
$35,672,737
Countries/Regions
Chemonics International:
$17,739,470
Countries/Regions
USG Aggregated Agencies:
$14,664,383
Countries/Regions
Deloitte Consulting Limited:
$13,725,011
Countries/Regions